Wei, D. Y. http://orcid.org/0000-0003-0644-7172
Moreno-Ajona, D. http://orcid.org/0000-0002-0366-5994
Renton, T. http://orcid.org/0000-0003-2331-4005
Goadsby, P. J. http://orcid.org/0000-0003-3260-5904
Article History
Received: 24 January 2019
Accepted: 30 May 2019
First Online: 11 June 2019
Ethics approval and consent to participate
: This clinical audit was registered in King’s College Hospital on 11th September 2016.
: Not applicable.
: DYW, DMA, TR have nothing to disclose. PJG has no conflict of interest with the submitted work. PJG reports personal fees from Alder Biopharmaceuticals, personal fees from Allergan, grants and personal fees from Amgen, personal fees from Autonomic Technologies Inc., personal fees from Biohaven Pharmaceuticals Inc., personal fees from Dr. Reddy’s Laboratories, grants and personal fees from Eli Lilly and Company, personal fees from Electrocore LLC, personal fees from eNeura Inc., personal fees from MundiPharma, from Novartis, personal fees from Teva Pharmaceuticals, other from Trigemina, outside the submitted work; In addition, PJG has a patent Magnetic stimulation for headache licensed to eNeura without fee and Fees for publishing from Oxford University Press, Massachusetts Medical Society, Wolters Kluwer and for medicolegal work.